Therapy - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #pharmaceutical #pharma #healthcare
Therapy - Pharmacy Times >> Comment below! #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #pharmaceutical #pharma #healthcare
New Heritage Capital just invested in Carepoint. Peak Rock also acquired Asembia (specialty infrastructure).
This space is getting a lot more attention than traditional retail right now.
www.morningstar.com/news/busines...
New Heritage Capital just invested in Carepoint. Peak Rock also acquired Asembia (specialty infrastructure).
This space is getting a lot more attention than traditional retail right now.
www.morningstar.com/news/busines...
Source
Source
Innovation isn’t the bottleneck in specialty pharma, access is. Barriers to cell & gene therapy, slow biosimilar uptake, and AI-driven decision-making are reshaping the landscape.
The takeaway? Access must be engineered earlier. lumanity.com/perspectives...
#MarketAccess #HEOR
Innovation isn’t the bottleneck in specialty pharma, access is. Barriers to cell & gene therapy, slow biosimilar uptake, and AI-driven decision-making are reshaping the landscape.
The takeaway? Access must be engineered earlier. lumanity.com/perspectives...
#MarketAccess #HEOR
Learn more at buff.ly/agpIQzW
#ASX25 #ASX2025 #Pharmacoeconomics #MarketAccess #HEOR #Asembia
Learn more at buff.ly/agpIQzW
#ASX25 #ASX2025 #Pharmacoeconomics #MarketAccess #HEOR #Asembia
#ASX25 #ASX2025 #Pharmacoeconomics #MarketAccess #HEOR #Asembia
#ASX25 #ASX2025 #Pharmacoeconomics #MarketAccess #HEOR #Asembia